JAMA today published outcomes from a study evaluating the safety and efficacy of the Insulet Omnipod 5 in adults with type 2 ...

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose ...

Wealth management firm Charles Schwab set out to determine which generation is the greediest. The results of their study were telling. The study revealed that baby boomers are the greediest ...

RUTHERFORD, N.J., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq ... Certificate of Amendment to effect the Reverse Stock Split at a ratio between 1-for-2 and 1-for-20, as determined by ...

RUTHERFORD, N.J., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq ... the Reverse Stock Split at a ratio between 1-for-2 and 1-for-20, as determined by the Board in its sole discretion.

(MENAFN- GlobeNewsWire - Nasdaq) 1-for-20 reverse stock split to become effective as of the opening of trading on February 4, 2025 RUTHERFORD, N.J., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Glucotrack ...

RUTHERFORD, N.J., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq ... the Reverse Stock Split at a ratio between 1-for-2 and 1-for-20, as determined by the Board in its sole discretion.

Glucotrack (GCTK),announced that it will effect a 1-for-20 reverse stock split of its issued and outstanding common stock par value $0.001 per share, effective with the opening of trading on ...

RUTHERFORD, N.J., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the ...

RUTHERFORD, N.J., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on ...